中财网 中财网股票行情
泽璟制药-U(688266)财务分析指标    年份：
截止日期2025-06-302025-03-312024-12-312024-09-302024-06-30
营业总收入(万元)37565.0316764.2053295.4438411.7224069.67
营业收入(万元)37565.0316764.2053295.4438411.7224069.67
营业总成本(万元)47516.8322489.1773065.6951277.8333353.05
营业成本(万元)3882.091946.783699.142702.451749.60
净利润(万元)-7322.03-2812.33-14635.54-7373.43-6625.12
归属于母公司的净利润(万元)-7280.35-2826.22-13783.08-9790.30-6653.61
营业利润(万元)-7673.12-3001.70-15504.32-11254.81-7943.60
利润总额(万元)-7741.50-3031.70-15504.78-11260.27-7949.34
少数股东损益(万元)-276.64-105.11-1246.75-1174.36-1099.16
基本每股收益(元)-0.28(元)-0.11(元)-0.52(元)-0.37(元)-0.25(元)
稀释每股收益(元)-0.28(元)-0.11(元)-0.52(元)-0.37(元)-0.25(元)
非经常性损益(万元)--2181.873332.95665.38583.52
扣除非经常性损益后净利润(万元)-10264.14-5008.10-17116.03-10455.68-7237.12
总资产(万元)299920.34291782.39300461.43296714.79309966.30
总负债(万元)182258.79169409.40175201.37166434.19153129.71
归属于母公司股东权益合计(万元)117661.54122601.30125385.79130338.75156704.45
股东权益合计(万元)117661.54122372.99125260.05130280.60156836.60
实收资本(股本)(万元)26470.8226470.8226470.8226470.8226470.82
资本公积(万元)311634.44312064.51312036.66309727.51335344.90
未分配利润(万元)-218954.60-214500.47-211674.25-207681.47-204544.78
经营活动产生的现金流量净额(万元)-1702.03-625.323820.456664.7111255.31
经营活动现金流入小计(万元)47514.3221678.1487282.9070286.4054016.21
经营活动现金流出小计(万元)49216.3522303.4683462.4563621.7042760.90
投资活动产生的现金流量净额(万元)-6234.26-2663.07-184510.14845.533558.78
投资活动现金流入小计(万元)1737.32717.74121708.86101686.5879926.45
投资活动现金流出小计(万元)7971.583380.81306219.00100841.0676367.67
筹资活动产生的现金流量净额(万元)2591.28-3179.61-5131.64-7812.564436.48
筹资活动现金流入小计(万元)43152.1114132.19128861.8579800.0052800.00
筹资活动现金流出小计(万元)40560.8317311.80133993.4987612.5648363.52
期末现金及现金等价物余额(万元)16336.1815257.6321726.55207421.72227031.99
最后修改日期2025-08-222025-04-212025-04-212024-10-292024-08-26
↑返回页顶↑

转至泽璟制药-U（688266）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。